Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Procrit Counterfeits Return: Contaminated Product Found In Florida

Executive Summary

Johnson & Johnson's Ortho Biotech division appears to have a recurring problem with counterfeiting of Procrit in Florida

You may also be interested in...



CBER Counterfeit Procedures Stress Need For Improved Communication

The Center for Biologics Evaluation & Research's standard procedures for responding to a counterfeit product event emphasizes the need for more efficient communication between FDA and outside parties

CBER Counterfeit Procedures Stress Need For Improved Communication

The Center for Biologics Evaluation & Research's standard procedures for responding to a counterfeit product event emphasizes the need for more efficient communication between FDA and outside parties

Manufacturers’ Anticounterfeiting Plans Sought In House Cmte. Investigation

The House Energy & Commerce Committee is asking five brand-name drug manufacturers to submit information on their efforts to prevent counterfeiting

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS041437

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel